Brian Richard MacDonald - 29 Dec 2022 Form 3 Insider Report for Disc Medicine, Inc. (IRON)

Role
Chief Innovation Officer
Signature
/s/ Rahul Khara, attorney-in-fact
Issuer symbol
IRON
Transactions as of
29 Dec 2022
Net transactions value
$0
Form type
3
Filing time
03 Jan 2023, 16:02:12 UTC
Next filing
30 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IRON Common Stock 27,400 29 Dec 2022 Direct
holding IRON Common Stock 1,096 29 Dec 2022 Held by Son F1
holding IRON Common Stock 1,096 29 Dec 2022 Held by Son F1
holding IRON Common Stock 1,096 29 Dec 2022 Held by Son F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IRON Stock Option (Right to Buy) 29 Dec 2022 Common Stock 37,214 $1.01 Direct F2
holding IRON Stock Option (Right to Buy) 29 Dec 2022 Common Stock 50,491 $9.86 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F2 8,503 shares underlying this option vested immediately upon grant, with the remaining shares vesting in 15 equal quarterly installments following September 13, 2019, subject to the Reporting Person's continued service on each such vesting date
F3 The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney